Literature DB >> 2102022

Vaccinations in the health strategies of developing countries.

R H Henderson1.   

Abstract

The initiative established by the World Health Organization in 1974 under the title of the Expanded Programme on Immunization (EPI) has resulted in immunization programmes being strengthened in developing countries so that they now cover 66% of children reaching their first birthday with a dose of DPT or polio vaccines. Immunization programmes are currently preventing over 2 million deaths among children in developing countries from measles, neonatal tetanus and whooping cough. Future challenges for the EPI include: raising and sustaining immunization coverage; controlling the target diseases, with specific focus on the control of measles, the elimination of neonatal tetanus and the eradication of poliomyelitis; introducing new or improved vaccines; promoting other primary health care practices; and research and development. Immunization will become an increasing priority for developing and industrialized countries alike as an increasing array of vaccines become available for public health use. Further research to simplify and reduce the costs of vaccine production and administration and to better understand the factors contributing to the acceptability of immunization services is needed as a complement to research to develop additional vaccines.

Entities:  

Mesh:

Year:  1990        PMID: 2102022

Source DB:  PubMed          Journal:  Scand J Infect Dis Suppl        ISSN: 0300-8878


  2 in total

1.  Maximizing immunization coverage through home visits: a controlled trial in an urban area of Ghana.

Authors:  R F Brugha; J P Kevany
Journal:  Bull World Health Organ       Date:  1996       Impact factor: 9.408

2.  Evaluation of an algorithm for the integrated management of childhood illness in an area with seasonal malaria in the Gambia.

Authors:  M W Weber; E K Mulholland; S Jaffar; H Troedsson; S Gove; B M Greenwood
Journal:  Bull World Health Organ       Date:  1997       Impact factor: 9.408

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.